Safety Evidence The overall safety profile of the FDCs was similar to those of the individual components
Neither is a substitute for real medical evaluation of persistent fatigue
2 In addition to being a major risk factor for cardiovascular disease, type-2 diabetes mellitus, and cancer, obesity also increases the risk of chronic pain syndromes, including headache disorders
All That Glitters Is Not Gold: Issues and Risks Around GLP-1 Medications The effectiveness of GLP-1 medications in promoting weight loss has led to a surge in off-label demand, particularly for cosmetic purposes
Changes in Digestion GLP-1 medications slow how quickly the stomach empties, known as delayed gastric emptying
A recent meta-analysis of mixed evidence (5 RCTs 52,183,184,185,186 and 1 cohort study 187 ) in 2,071 people with T2DM or Parkinsons disease suggested antidepressant efficacy of the GLP-1RAs exenatide and liraglutide over 2452 weeks 188